These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 4323972)
1. Treatment of ocular myasthenia with corticotrophin. Gibberd FB; Navab F; Smith CL J Neurol Neurosurg Psychiatry; 1971 Feb; 34(1):11-3. PubMed ID: 4323972 [TBL] [Abstract][Full Text] [Related]
2. Corticotropin and corticosteroids in generalized myasthenia gravis: comparative studies and role in management. Brunner NG; Berger CL; Namba T; Grob D Ann N Y Acad Sci; 1976; 274():577-95. PubMed ID: 183590 [TBL] [Abstract][Full Text] [Related]
3. Corticotropin in generalized myasthenia gravis. Effect of short, intensive courses. Grob D; Namba T JAMA; 1966 Nov; 198(7):703-7. PubMed ID: 4288482 [No Abstract] [Full Text] [Related]
4. Benefit from adrenocorticotrophin in myasthenia gravis. Liversedge LA; Yuill GM; Wilkinson IM; Hughes JA J Neurol Neurosurg Psychiatry; 1974 Apr; 37(4):412-5. PubMed ID: 4365243 [TBL] [Abstract][Full Text] [Related]
6. EMG findings in mild cases of myasthenia gravis during and after a short course of moderate doses of ACTH. Pinelli P Electroencephalogr Clin Neurophysiol; 1968 Jul; 25(1):82. PubMed ID: 4174788 [No Abstract] [Full Text] [Related]
7. Treatment of severe myasthenia gravis with large doses of ACTH. von Reis G; Liljestrand A; Matell G Ann N Y Acad Sci; 1966 Jan; 135(1):409-16. PubMed ID: 4287550 [No Abstract] [Full Text] [Related]
8. Medical and surgical treatment for ocular myasthenia. Benatar M; Kaminski H Cochrane Database Syst Rev; 2006 Apr; (2):CD005081. PubMed ID: 16625623 [TBL] [Abstract][Full Text] [Related]
9. Short-term intensive corticotrophin treatment in myasthenia gravis. Liversedge LA Proc R Soc Med; 1971 May; 64(5):492. PubMed ID: 4325184 [No Abstract] [Full Text] [Related]
11. Corticotropin therapy and thymectomy in management of myasthenia gravis. Shapiro MS; Namba T; Grob D Arch Neurol; 1971 Jan; 24(1):65-71. PubMed ID: 4322008 [No Abstract] [Full Text] [Related]
12. Corticotropin therapy in myasthenia gravis: effects, indications, and limitations. Namba T; Brunner NG; Shapiro MS; Grob D Neurology; 1971 Oct; 21(10):1008-18. PubMed ID: 4329627 [No Abstract] [Full Text] [Related]
13. Ocular myasthenia gravis in an academic neuro-ophthalmology clinic: clinical features and therapeutic response. Mittal MK; Barohn RJ; Pasnoor M; McVey A; Herbelin L; Whittaker T; Dimachkie M J Clin Neuromuscul Dis; 2011 Sep; 13(1):46-52. PubMed ID: 22361625 [TBL] [Abstract][Full Text] [Related]
14. Value of exchangeable electrolyte measurement in the treatment of myasthenia gravis. Critchley M; Herman KJ; Harrison M; Shields RA; Liversedge LA J Neurol Neurosurg Psychiatry; 1977 Mar; 40(3):250-2. PubMed ID: 196049 [TBL] [Abstract][Full Text] [Related]
15. Treatment of myasthenia gravis with adrenocorticotropic hormone (ACTH): massive short-term and maintenance treatment. Cape CA; Utterback RA J Neurol Neurosurg Psychiatry; 1969 Aug; 32(4):290-6. PubMed ID: 4309018 [No Abstract] [Full Text] [Related]
16. Treatment of ocular symptoms in myasthenia gravis. Bhanushali MJ; Wuu J; Benatar M Neurology; 2008 Oct; 71(17):1335-41. PubMed ID: 18936425 [TBL] [Abstract][Full Text] [Related]
17. Delayed remission after thymectomy for myasthenia gravis of the purely ocular type. Nakamura H; Taniguchi Y; Suzuki Y; Tanaka Y; Ishiguro K; Fukuda M; Hara H; Mori T J Thorac Cardiovasc Surg; 1996 Aug; 112(2):371-5. PubMed ID: 8751505 [TBL] [Abstract][Full Text] [Related]